# US 2004/0082032 A1 · Cctra gene as a tool to produce male-only progeny in the mediterranean fruitfly ceratitis capitata

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082032 A1
- Document ID: US20040082032A1
- Status: Published application
- Kind: A1
- Application number: 10/471,211
- Filed: 2003-09-08
- Published: 2004-04-29
- Earliest claimed: 2001-03-08
- Inventors: Pasquale Delli Bovi; Attilio Pane; Catello Polito; Giuseppe Saccone
- Web page: https://patentgrep.com/patent/US20040082032A1

## CPC

- C07K 14/43577: {from flies}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention refers to the identification of the Cctra gene (SEQ.ID.NO. 1) and to corresponding dsRNA molecules comprising Cctra gene.sequences as a tool to produce only-male progeny in the Mediterranean fruitfly Ceratitis capitata.

## Claims

### Claim 1

Ceratitis capitata gene Cctra encoding the protein CcTRA able to regulate the sexual phenotype of dipteran species, in particular of Ceratitis capitata.

### Claim 2

Cctra cDNA isolated and derived from the male-specific mRNA.

### Claim 3

Cctra cDNA isolated female-specific indicated as Seq. IDN 1.

### Claim 4

Nucleotide sequence isolated corresponding to the female-specific cDNA indicated as Seq. IDN 1.

### Claim 5 (depends on 4)

Nucleotide sequence according to claim 4 which encode a polypeptide or a peptide comprised into the Seq IDN: 2.

### Claim 6

Polynucleotide or oligonucleotide isolated comprising portions of the nucleotide sequence indicated as Seq. IDN1.

### Claim 7 (depends on 6)

Polynucleotide or oligonucleotide 60% homologous or more to the polynucleodotide or oligonucleotide according to claim 6.

### Claim 8 (depends on 6)

Polynucleotide or oligonucleotide 80% homologous or more to the polynucleodotide or oligonucleotide according to claim 6.

### Claim 9

Aminoacidic sequence isolated indicated as Seq. IDN 2.

### Claim 10

Cctra nucleotide sequence encoding for the aminoacidic region corresponding to the box 1 of FIG. 3.

### Claim 11

Cctra nucleotide sequence encoding for the aminoacidic region corresponding to the box 2 of FIG. 3.

### Claim 12

Cctra nucleotide sequence encoding for the aminoacidic region corresponding to the box 3 of FIG. 3.

### Claim 13

Cctra nucleotide sequence encoding for the aminoacidic region corresponding to the box 4 of FIG. 3.

### Claim 14 (depends on 10, 11, 12, 13)

Nucleotide sequence complementary to the sequences according to claims 10-13.

### Claim 15 (depends on 10, 11, 12, 13)

Polypeptide or peptide 40% homologous or more to the aminoacidic sequences according to claims 10-13.

### Claim 16 (depends on 10, 11, 12, 13)

Polypeptide or peptide 60% homologous or more to the aminoacidic sequences according to claims 10-13.

### Claim 17 (depends on 10, 11, 12, 13)

Polypeptide or peptide 80% homologous or more to the aminoacidic sequences according to claims 10-13.

### Claim 18 (depends on 2, 3)

Antisense oligonucleotide able to hybridize with the mRNA derived from the cDNA according to claims 2 and 3.

### Claim 19

Polynucleotide or polypeptide sequence according to previous claims to be used to regulate the sex determination of the dipteran.

### Claim 20 (depends on 19)

Sequence according to claim 19 wherein the dipteran is selected among:
Glossina, Anophelese gambiae, Aedis Egypti, Ceratitis capitata.

### Claim 21

Antibody against the Cctra protein.

### Claim 22 (depends on 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13)

Plasmid comprising the polynucleotide or oligonucleotide according to claims 2-8 and 10-13.

### Claim 23 (depends on 21)

Plasmid according to claim 21 to be used as cloning and expression vector.

### Claim 24 (depends on 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13)

Vector including the polynucleotide and oligonucleotide according to claims 2-8 and 10-13.

### Claim 25 (depends on 23)

Vector according to claim 23 further comprising a gene encoding a fluorescent protein.

### Claim 26 (depends on 21, 22)

Cell modified with a plasmid according to claims 21-22.

### Claim 27 (depends on 25)

Cell modified according to claim 25 able to express the CcTRA protein or subfragments or its homologous proteins with a 40% of homology or more.

### Claim 28 (depends on 25, 26)

Pluricellular organism, exclude humans, comprising cells modified according to claims 25-26.

### Claim 29

Transgenic non human animals “knock our” in which the Cctra gene is partially or fully inactivated.

### Claim 30 (depends on 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13)

Use of the nucleotide or polypeptide sequences according to claims 2-8 and 10-13, or parts of these sequences, as regulators of the sex determination in dipteran.

### Claim 31 (depends on 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13)

Use of the nucleotide or polypeptide sequences according to claims 2-8 and 10-13, or parts of these sequences, as regulators of sex determination in a dipterian selected among: Glossina, Anophelese gambiae, Aedis Egypti, Ceratitis capitata.

### Claim 32 (depends on 1)

Method of gene silencing mediated by dsRNA molecules with a sequence specific for the Cctra gene according to the claim 1.

### Claim 33 (depends on 31)

Method according to claim 31 performed injecting dsRNA molecules, artificially produced from a cDNA clone of Cctra into dipteran embryos to induce a reversion of the sexual phenotype from female to male one.

### Claim 34 (depends on 32)

Method according to claim 32 in which the embryos are of Ceratitis capitata.

### Claim 35 (depends on 32)

Method according to claim 32 in which the region chosen for the silencing is extended from the position 154 (exon 1) to the position 893 (exon 5) of the female-specific cDNA SEQ IDN 1 of Cctra and corresponds to exonic regions present into the clone of F1 cDNA-and into the M1 cDNA clone.

### Claim 36 (depends on 31, 32, 33, 34)

Method of gene silencing according to claims 31-34 performed by the use of a transformation vector by which an inducible transgene that produces Cctra—specific dsRNA molecules is introduced into the Ceratitis genome.

### Claim 37 (depends on 32, 33, 34, 35)

Method of gene silencing according to claims 32-35 in which antisense DNA or RNA molecules having specific sequences complementary to Cctra transcripts are injected or antibodies able to recognize the protein CcTRAF.

### Claim 38 (depends on 32)

Method according to claim 32 in which the injection is substituted with techniques selected between lipofection and electroporation.

### Claim 39 (depends on 1)

Cctra gene according to claim 1 comprising 5 exons of which 2 are male-specific.

### Claim 40

Process to produce Cctra dsRNA characterized by the use of 4 synthetic oligonucleotides named: 154+, 154+/T7, 893− and 893−/T7 with the sequence of the Cctra cDNA F1 as template.

### Claim 41 (depends on 39)

Process according to claim 39 in which the oligonucleotides 154+/T7 and 893−/T7 show at the 5′ end the sequence of the promoter for the phage T7 RNA Polymerase.

### Claim 42 (depends on 39, 40)

dsR4NA produced according to claims 39-40 to be injected into the embryos of dipteran species at the posterior or anterior poles to obtain a sex-specific selection.

### Claim 43

Use of the nucleotide sequence of the F1 cDNA containing the exonic regions of Cctra gene to eliminate from the progeny of the dipteran species, in particular of Ceratitis, the presence of the females transforming them into males.

### Claim 44

Transgenic strain which produces by an inducible way dsRNA with sequences specific to the Cctra gene.

### Claim 45

Cctra-GFP chimeric transgene encoding for a fluorescent protein.

### Claim 46 (depends on 44)

Process to separate XX embryos from XY embryos characterized by the use of the transgene according to claim 44 which express sex-specifically fluorescent proteins of different colors.

### Claim 47

Process to amplify Y-specific sequences by the Taq Polymerase characterized by the use of an oligonucleotide as primer selected among:
1-Y-SPECIFIC: 5′-GCGTTTAAATATACAAATGTGTG-3′ (SEQ. ID. NO. 3) 1 KbY-SPECIFIC: 5′-TACGCTACGAATAACGAATTGG 3′ (SEQ. ID. NO. 4)

### Claim 48

Process to amplify a DNA fragment of the Cctra locus by the following sequence:
Cctra 1113-5′ CTGGAACTGGCACTGGTATTG 3′ (SEQ. ID. NO. 5)

### Claim 49

Process to amplify an RNA fragment from males and females dipteran insects by PCR characterized by the use of the following primers:
F+=5′ CATGAACATGAATATTACAAAGGC 3′ (SEQ. ID. NO. 6)
Z1−=5′ CACGACGCTTATAGCTGTTGT 3′ (SEQ. ID. NO. 7)

### Claim 50

Oligonucleotide selected among:
Cctra 154+: 5′ CAGTGGTTCGGTTCGGAAG 3′ (SEQ. ID. NO. 8)
Cctra 893−: 5′ TCCATGATGTCGATATTGTCC 3′ (SEQ. ID. NO. 9)
Cctra 154+/T7: 5′ TAATACGACTCACTATAGGGCAGTGGTTCGGTTCGGAAG 3′ (SEQ. ID. NO. 10)
Cctra 893−/T7: 5′ TAATACGACTCACTATAGGGTCCATGATGTCGATATTGTCC 3′ (SEQ. ID. NO. 11)
to obtain the dsRNA of Cctra.
